SafeGuard Surgical
Medical innovations of the future, healing patients today.
Medical innovations of the future, healing patients today.
SafeGuard Surgical provides needed products that will ensure safer surgery for superior patient outcomes while reducing costs, preventing additional surgical interventions and reducing patient length of stay, but most importantly preventing mortality and morbidity which is much too common risk from surgery.
Our mission is a scalable and sustainable innovative global outreach to improve surgical outcomes in advanced surgical procedures adapting US ideas in underdeveloped and advancing outcomes in contemporary nations.
Our focus is attention specific to emerging markets, underserved and developing nations to prevent common leaks that have alarming mortality rates in the international community.
The United States is the world's largest medical device market and it shows no signs of slowing. The US medical device industry is valued at $159 billion in 2022 and is poised for steady growth, with global annual sales forecast to rise by over 5 percent a year and reach nearly US$800 billion by 2030 U.S. health care spending grew 9.7 percent in 2020, reaching $4.1 trillion or $12,530 per person. As a share of the nation's Gross Domestic Product, health spending accounted for 19.7 percent.
We work with surgical oncologists, general surgeons, colon and rectal surgeons, and bariatric surgeons. Current products and services in development are:
LeakGuard’s SAM is $4.5B for 600,000 colectomies performed in the United States each year
So far, SafeGuard Surgical is 100% bootstrapped for over $400,000 and plans to go public or get acquired by the end of 2024.
CEO, Inventor, Co-Founder
Dr. Kelley is a surgical oncologist trained in the surgical treatment of gastrointestinal malignancies of esophagus, pancreatic, stomach, colon and rectal, and hepatobiliary malignancies. He attended Dartmouth College and Columbia Medical School, and then completed General Surgery residency at the University of Pennsylvania and Surgical Oncology Fellowship at the H. Lee Moffitt Cancer Center. Dr Kelley has developed several patents across a wide range of domains.
Co-Founder
Jill Kelley is the first Arab American female founder of a medical biotech company and blockchain technology company. As a Lebanese immigrant, Jill has always been intensely interested in STEM and a zealous advocate of women led/purpose driven technology companies. As the former honorary military ambassador to our over 60 countries under Secretary of Defense General James Mattis, Jill continues to advise embassies and multinational companies while sitting on boards of publicly traded companies.
Case Team Leader, Class of 2024
Analyst, Class of 2024
Analyst, Class of 2025
Analyst, Class of 2025
Analyst, Class of 2026
MD of Partnerships, Class of 2024
President & Chief Executive Officer at Synchromune. Previously he was a Visiting Scholar and Entrepreneur in Residence for the Translational Accelerator at Brigham and Women’s Hospital, Harvard Medical School.
Co-founder of Glycyx, previous CEO and co-founder of Mobile Sense where he led the development and design, clinical trial, and partnerships. He was also a commercial leader at Johnson & Johnson and a business development executive at Purdue Pharma.
CEO and COO of Phoenicis. Deborah has previously held positions at Lotus Tissue Repair, Inc., CMS International, Inc., Phoenicis Therapeutics, Orphan Technologies, Valerion Therapeutics, and Alopexx Enterprises. Ramsdell has over 28 years of experience in the regulatory affairs and clinical operations field.
Peter Zaffaroni is an associate in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he practices corporate and securities law.
Partner at the Edgewood Group., a family office based in Silicon Valley. He is a senior advisor to the Honorable Dick Gephardt and Honorable Secretary Michael Chertoff.
Entrepreneur-in-residence at the University of Miami. co-inventor of the EpiPen and Holter Monitor.
Accomplished preclinical and clinical director with over 20 years of experience in medical device development.
jill@safeguardsurgical.com
Copyright © 2019 SafeGuard Surgical LLC